Europe has much that is new—including innovative research—emerging from its old-world settings
Expression of CD154 Protein Linked to Increased Risk for Developing RA
An ongoing study of key immune system proteins has pinpointed an area associated with increased risk for inflammatory disease and may one day lead to new therapies to control inflammation and rheumatic diseases.
New Approaches to Inflammatory Myopathy
Advances in diagnostic modalities and treatments emerge
Family, Fatigue & Heart Health
Researchers explore several factors in the health and well-being of patients with lupus
Rheum with a View
Panush’s perspectives on selections from the literature
Chronotherapy with Glucorticoids in Rheumatoid Arthritis
Time is of the essence in balancing risks and benefits
The Calling of the “Inner Nerd”
Trainees shouldn’t be afraid to live the life of lab and academic research
New ACR and ARHP Leaders Join the Ranks
The ACR is pleased to welcome new and returning leaders to the ACR board of directors and ARHP executive committee who were appointed in November. The following members were selected to serve as the newest members-at-large of the ACR board of directors. Each of them shared what they will bring to the table.
A Review of Wegener’s Treatment Data
Clinical trials show changing role of existing treatment and introduction of newer medications
Drug UPDATES
Information on New Approvals and Medication Safety
- « Previous Page
- 1
- …
- 101
- 102
- 103
- 104
- 105
- …
- 123
- Next Page »